carteolol has been researched along with atrial natriuretic factor in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ferrier, C; Morger, D; Saxenhofer, H; Shaw, SG; Weidmann, P | 1 |
| Kohno, M; Kurihara, N; Murakawa, K; Takeda, T; Yasunari, K; Yokokawa, K | 1 |
| Akaishi, M; Anzai, T; Baba, A; Handa, S; Mitamura, H; Nishimura, H; Ogawa, S; Yoshikawa, T | 1 |
3 trial(s) available for carteolol and atrial natriuretic factor
| Article | Year |
|---|---|
Modulation of noradrenergic but not angiotensinergic blood pressure control by beta-blockade with carteolol.
Topics: Adult; Angiotensin II; Atrial Natriuretic Factor; Blood Pressure; Carteolol; Female; Humans; Hypertension; Isoproterenol; Male; Norepinephrine; Receptors, Adrenergic, beta; Single-Blind Method | 1991 |
Acute effects of alpha- and beta-adrenoceptor blockade on plasma atrial natriuretic peptides during exercise in elderly patients with mild hypertension.
Topics: Aged; Atenolol; Atrial Natriuretic Factor; Carteolol; Exercise; Female; Humans; Hypertension; Male; Middle Aged; Multivariate Analysis; Prazosin; Ventricular Function, Left | 1991 |
Early reduction of neurohumoral factors plays a key role in mediating the efficacy of beta-blocker therapy for congestive heart failure.
Topics: Adrenergic beta-Antagonists; Arginine Vasopressin; Atrial Natriuretic Factor; Carteolol; Female; Heart Failure; Humans; Lymphocytes; Male; Middle Aged; Myocardial Contraction; Norepinephrine; Propanolamines; Receptors, Adrenergic, beta; Renin-Angiotensin System; Time Factors; Ventricular Function, Left | 1996 |